Nav: Home

Max Planck and Taylor & Francis Group sign open-access agreement

January 17, 2017

The Max Planck Digital Library and Taylor & Francis Group have signed an agreement which enables researchers based in Max Planck institutes to publish open access in 2,390 journals, under a centrally funded arrangement. This applies to peer-reviewed papers in full and hybrid Taylor & Francis Group journals, including Routledge and Cogent OA titles.

Max Planck Institutes will also have shared access to a set of Taylor & Francis subscription journals and can swap and add individual titles up to an agreed limit to meet reader demand.

Dr. Ralf Schimmer, Head of Information at the Max Planck Digital Library, said, "This new agreement is constructed from an open access perspective and helped us to revitalize our business relations after several years of no central site license for the Max Planck Society. We are particularly pleased that our new collaboration marks a departure from the subscription system and shifts our fees from read access to our publication output. This constitutes a significant service improvement for our authors and underscores the transformation to open access."

The agreement offers an increase in open access publishing options for Max Planck researchers, with Taylor & Francis' portfolio of titles stretching across the sciences, medicine, social sciences and humanities. All corresponding authors based at a Max Planck Institute will now be eligible to have their manuscript published gold open access under a CC BY license.

Individual authors will no longer be required to pay the article publishing charges usually applicable for open access publication. Payments by MPDL to support the agreement will transition over three years to directly reflect the number of Max Planck researchers publishing in Taylor & Francis Group journals.

The Max Planck Digital Library has published information for their authors and researchers on their website.

Deborah Kahn, Publishing Director (Open Access and Medicine) at Taylor & Francis Group, said, "The Max Planck Society, a leader in many research fields, has also led the way in establishing Open Access as a flexible and high?quality scholarly and scientific publishing system ever since they organized the first Berlin Conference in 2003. We are therefore delighted to be partnering with Max Planck Digital Library to facilitate all Max Planck researchers being able to publish Open Access in all of our Cogent, Taylor & Francis Open and Open Select journals, as well as providing them easy and unrestricted access to many of our leading titles."
-end-


Taylor & Francis Group

Related Open Access Articles:

Endocrine Society launches first open-access journal
The Endocrine Society unveiled the first issue of its open-access scholarly publication the Journal of the Endocrine Society today, marking the first time the society has introduced a new journal under its ownership in nearly 30 years.
ASH launches digital, open-access journal
Launching today, the open-access online journal Blood Advances will fill a niche that complements and expands on topics covered in Blood while also transforming the conversation between authors and readers through innovative communication tools.
Leading STEM publisher launches open access platform
Mary Ann Liebert Inc. publishers announces the launch of its LiebertOpenAccess.com platform, featuring the company's open-access publications and services in one online destination.
BMJ launches new open access ophthalmology journal
Healthcare knowledge provider BMJ has added a new title to its expanding portfolio of 60 specialist journals, with the launch of BMJ Open Ophthalmology later this month.
Elsevier selected to publish open-access journal: Engineering
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it has been selected to publish Engineering, an open-access journal published in collaboration with the Chinese Academy of Engineering.
Adis launches new open access pharmacoeconomics journal
Adis, a leading global provider of drug information, is launching a new open access pharmacoeconomics journal, which will be added to their portfolio in 2017.
New open access publishing platform for scientific research now live
Canadian Science Publishing (CSP) is pleased to announce that FACETS, Canada's first and only multidisciplinary open access science journal, has now fully launched.
Endocrine Society unveils plans for open-access journal
This fall, the Endocrine Society will launch its first open-access journal to speed the process of sharing endocrine research breakthroughs with scientists, health-care providers and the public, the society announced at its annual meeting.
Use of open access platforms for clinical trial data
In a study appearing in the March 22/29 issue of JAMA, Ann Marie Navar, M.D., Ph.D., of Duke University Medical Center, Durham, NC, and colleagues examined how shared clinical trial data are being used.
New open-access data on paleofloods
Whether extreme river floods are becoming more frequent and/or severe in a warming world remains under debate, partly because instrumental measurements of river discharge are too restricted in length to detect shifts from natural variability.

Related Open Access Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...